Evaluation of the Effectiveness of an Alcohol Based Hand Gel for the Reduction of Warts on the Hands (NCT00973856) | Clinical Trial Compass
CompletedNot Applicable
Evaluation of the Effectiveness of an Alcohol Based Hand Gel for the Reduction of Warts on the Hands
United States5 participantsStarted 2009-09
Plain-language summary
The objective is to conduct a pilot study to determine the effectiveness of PURELL VF481 to treat warts located on the hands.
Who can participate
Age range
18 Years – 75 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Patients with 2+ warts being seen at a Dermatologist's office
* 2 or more warts on the hands that are located at least 1 cm apart or on separate fingers
* Warts must have been present for at least 2 months
* Wart size must be between 2 mm-15 mm in diameter
* Participants must be in good general health
* Participants must be able to speak and read in English.
* Participant must be able to read and sign participant instruction sheet, and informed consent and authorization.
* Subjects must be able to understand and execute the instructions presented in pictorial form.
Exclusion Criteria:
* Pregnancy (Patients will be asked to verify using criteria of contraception, menstrual cycle, and pregnancy test, if necessary).
* Treatment of warts with other methods such as salicylic acid, etc., in the past 14 days.
* Known allergies to common topical antimicrobials or the individual ingredients in either test product.
* Participation in a clinical study in the past 7 days or participation in another clinical study
* Unwillingness to perform requirements of the study
* Any medical condition that should preclude participation in the study, at the discretion of the physician
* Missed ≥ 6 of the treatments in a 4 week study period
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Difference in % Reduction in Wart Size Between Product A and Product B at Each Timepoint
Timeframe: Baseline, 4, 8, and 12 weeks, change at 12 weeks reported